Israel Englander Adicet Bio, Inc. Call Options Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$5.52 - $9.23 $563,040 - $941,460	102,000 Added 204.0%	152,000 $876,000
Q4 2022 Feb 14, 2023	SELL	$7.72 - $21.27 $424,600 - $1.17 Million	-55,000 Reduced 52.38%	50,000 $447,000
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $1.41 Million - $1.97 Million	105,000 New	105,000 $1.49 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36.4M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.